Hints and tips:
...In 2019, Namal Nawana, an Australian who had worked in the US, quit as chief executive of Smith & Nephew because the UK medical devices company could not meet his pay demands....
...Smith & Nephew has held talks to buy NuVasive, a maker of medical instruments used in spinal surgery, in a deal that would be worth more than $3bn and mark the largest acquisition by the British medical...
...But in his 18-month stint at Smith & Nephew, Mr Nawana oversaw a 40 per cent increase in its share price....
...FTSE 100 group Smith & Nephew had an even worse April than ITV. April revenues for the medical devices maker dropped 47 per cent, as elective surgeries have come to a halt in many countries....
...The lockdowns imposed to contain the virus are likely to have hit sales of drugs that need a doctor to administer them, while the delay in non-essential surgeries has hurt others including Smith & Nephew...
...Namal Nawana: competitive spirit UK medical devices maker Smith & Nephew seems keen to shift its listing to the US. That would give it a freer rein to raise the pay of chief exec Namal Nawana....
...Smith & Nephew opens up the hunt Namal Nawana couldn’t have been more clear with his investors last week....
...Smith & Nephew, another Elliott target, jumped to a five-month high amid a retread of takeover speculation around the orthopaedic devices maker....
...Mr Nawana takes over as Smith & Nephew is facing pressure from activist investor Elliott Advisors, which has been pressing for divestments....
...Corporate earnings reports out today include Air France-KLM, Smith & Nephew, Société Générale and Repsol....
...for Smith & Nephew....
...Medical devices maker Smith & Nephew is planning to return $300m to shareholders through a share buyback, after agreeing to sell its gynaecology business to rival equipment maker, Medtronic....
...Its finance director Carol Fairweather was also replaced by Julie Brown, who joined from Smith & Nephew, the UK medical device company....
...Bookrunners such as BAML, Goldman and UBS may seek to price ConvaTec closer to Denmark’s Coloplast than Smith & Nephew of the UK....
...& Nephew also opposed the pay of its boss Olivier Bohuon....
...Mr Paul then went on to name — co-opting them to the cause — previous luminaries of sport who had some emancipatory role: “Jesse Owens, Jackie Robinson, Muhammad Ali, John Carlos and Tommie Smith, Kareem...
...Is Smith & Nephew the one that got away? The UK medical device maker has long been seen as a potential target for bigger US rivals....
...He was not a director of Queensland Nickel, which was run by his nephew Clive Mensink when the donations were made....
...Since the survey, there have been some significant digital appointments, for example, Erik Engstrom at Smith & Nephew and Shazam’s executive chairman Andrew Fisher joining the board of Moneysupermarket.com...
...Smith & Nephew dropped 4.7 per cent to £10.96 after management gave a cautious message on 2016, with China slowing and currency hedging contracts rolling off....
...Smith & Nephew, the medical devices maker, has also been the subject of some takeover speculation, and fell 3.3 per cent to £10.33....
...Smith & Nephew remains the London market’s favourite gambling chip....
...Smith & Nephew, the medical devices maker that has also been at the centre of transatlantic bid speculation, fell 2 per cent to £10.43....
...Smith & Nephew shares fell 0.6 per cent to 914p. They have risen almost 25 per cent in a year....
...AstraZeneca, the UK drugmaker which was the subject of a failed £69.4bn bid from Pfizer in May, was down 3.6 per cent, while Smith & Nephew, the UK medical devices maker considered to be another inversion...
International Edition